Enterprise Value
46.64M
Cash
17.41M
Avg Qtr Burn
-4.784M
Short % of Float
0.05%
Insider Ownership
50.47%
Institutional Own.
2.45%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HCW9218 Details Solid tumor/s, Pancreatic cancer, Cancer | Phase 1b Data readout | |
HCW9218 Details Cancer, Solid tumor/s, Ovarian cancer | Phase 1 Data readout |